Several clinical studies indicated that the daily use of aspirin or acetylsalicylic acid reduces the cancer risk via cyclooxygenases (Cox-1 and Cox-2) inhibition. In addition, aspirin-induced Cox-dependent and -independent antitumor effects have also been described. Here we report, for the first time, that aspirin treatment of human glioblastoma cancer (GBM) stem cells, a small population responsible for tumor progression and recurrence, is associated with reduced cell proliferation and motility. Aspirin did not interfere with cell viability but induced cell-cycle arrest. Exogenous prostaglandin E2 significantly increased cell proliferation but did not abrogate the aspirin-mediated growth inhibition, suggesting a Cox-independent mechanism. These effects appear to be mediated by the increase of p21 waf1 and p27 Kip1, associated with a reduction of Cyclin D1 and Rb1 protein phosphorylation, and involve the downregulation of key molecules responsible for tumor development, that is, Notch1, Sox2, Stat3, and Survivin. Our results support a possible role of aspirin as adjunctive therapy in the clinical management of GBM patients.

Pozzoli, G., Marei, H. E., Althani, A., Boninsegna Lucarelli, A., Casalbore, P., Marlier, L. N. J. L., Lanzilli, G., Zonfrillo, M., Petrucci, G., Rocca, B., Navarra, P., Sgambato, A., Cenciarelli, C., Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation, <<JOURNAL OF CELLULAR PHYSIOLOGY>>, N/A; 234 (9): 15459-15471. [doi:10.1002/jcp.28194] [http://hdl.handle.net/10807/130501]

Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation

Pozzoli, Giacomo;Boninsegna Lucarelli, Alma;Petrucci, Giovanna;Rocca, Bianca;Navarra, Pierluigi;Sgambato, Alessandro;
2019

Abstract

Several clinical studies indicated that the daily use of aspirin or acetylsalicylic acid reduces the cancer risk via cyclooxygenases (Cox-1 and Cox-2) inhibition. In addition, aspirin-induced Cox-dependent and -independent antitumor effects have also been described. Here we report, for the first time, that aspirin treatment of human glioblastoma cancer (GBM) stem cells, a small population responsible for tumor progression and recurrence, is associated with reduced cell proliferation and motility. Aspirin did not interfere with cell viability but induced cell-cycle arrest. Exogenous prostaglandin E2 significantly increased cell proliferation but did not abrogate the aspirin-mediated growth inhibition, suggesting a Cox-independent mechanism. These effects appear to be mediated by the increase of p21 waf1 and p27 Kip1, associated with a reduction of Cyclin D1 and Rb1 protein phosphorylation, and involve the downregulation of key molecules responsible for tumor development, that is, Notch1, Sox2, Stat3, and Survivin. Our results support a possible role of aspirin as adjunctive therapy in the clinical management of GBM patients.
2019
Inglese
Pozzoli, G., Marei, H. E., Althani, A., Boninsegna Lucarelli, A., Casalbore, P., Marlier, L. N. J. L., Lanzilli, G., Zonfrillo, M., Petrucci, G., Rocca, B., Navarra, P., Sgambato, A., Cenciarelli, C., Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation, <<JOURNAL OF CELLULAR PHYSIOLOGY>>, N/A; 234 (9): 15459-15471. [doi:10.1002/jcp.28194] [http://hdl.handle.net/10807/130501]
File in questo prodotto:
File Dimensione Formato  
130501.pdf

non disponibili

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Non specificato
Dimensione 1.89 MB
Formato Unknown
1.89 MB Unknown   Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/130501
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 16
social impact